Literature DB >> 16376999

Paradox of Ca2+ signaling, cell death and stroke.

John F MacDonald1, Zhi-Gang Xiong, Michael F Jackson.   

Abstract

Since the early 1960s it has been known that restoring extracellular Ca2+ following a period of low Ca2+ concentrations paradoxically causes an increase in intracellular Ca2+ levels that can lead to cell death. The mystery of this 'Ca2+ paradox' is made more intriguing by observations that lowering concentrations of extracellular Ca2+ and/or Mg2+ paradoxically enhances the entry of Ca2+ into hippocampal neurons. Until recently, the entry of Ca2+ through NMDA receptors was accepted as the major pathway leading to the excitotoxic, delayed cell death associated with the ischemic periods of stroke. Here, we discuss how several transient receptor potential (TRP) channels are likely to contribute to both the Ca2+ paradox and the delayed death of neurons following an ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16376999     DOI: 10.1016/j.tins.2005.12.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  48 in total

Review 1.  Acidosis, acid-sensing ion channels, and neuronal cell death.

Authors:  Yi-Zhi Wang; Tian-Le Xu
Journal:  Mol Neurobiol       Date:  2011-09-20       Impact factor: 5.590

Review 2.  Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection.

Authors:  Gregor Zündorf; Georg Reiser
Journal:  Antioxid Redox Signal       Date:  2010-10-06       Impact factor: 8.401

Review 3.  NAD+ depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death?

Authors:  C Siegel; L D McCullough
Journal:  Acta Physiol (Oxf)       Date:  2011-01-19       Impact factor: 6.311

4.  Extracellular calcium controls background current and neuronal excitability via an UNC79-UNC80-NALCN cation channel complex.

Authors:  Boxun Lu; Qi Zhang; Haikun Wang; Yan Wang; Manabu Nakayama; Dejian Ren
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

Review 5.  Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease.

Authors:  Grace E Stutzmann; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

6.  Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.

Authors:  Fadi F Hamdan; Julie Gauthier; Yoichi Araki; Da-Ting Lin; Yuhki Yoshizawa; Kyohei Higashi; A-Reum Park; Dan Spiegelman; Sylvia Dobrzeniecka; Amélie Piton; Hideyuki Tomitori; Hussein Daoud; Christine Massicotte; Edouard Henrion; Ousmane Diallo; Masoud Shekarabi; Claude Marineau; Michael Shevell; Bruno Maranda; Grant Mitchell; Amélie Nadeau; Guy D'Anjou; Michel Vanasse; Myriam Srour; Ronald G Lafrenière; Pierre Drapeau; Jean Claude Lacaille; Eunjoon Kim; Jae-Ran Lee; Kazuei Igarashi; Richard L Huganir; Guy A Rouleau; Jacques L Michaud
Journal:  Am J Hum Genet       Date:  2011-03-03       Impact factor: 11.025

Review 7.  The pharmacology and therapeutic potential of small molecule inhibitors of acid-sensing ion channels in stroke intervention.

Authors:  Tian-dong Leng; Zhi-gang Xiong
Journal:  Acta Pharmacol Sin       Date:  2012-07-23       Impact factor: 6.150

Review 8.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 9.  The effects of estrogen in ischemic stroke.

Authors:  Edward C Koellhoffer; Louise D McCullough
Journal:  Transl Stroke Res       Date:  2012-12-07       Impact factor: 6.829

Review 10.  Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke?

Authors:  Tiandong Leng; Yejie Shi; Zhi-Gang Xiong; Dandan Sun
Journal:  Prog Neurobiol       Date:  2014-01-24       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.